Patents by Inventor Ana Maria Gamo Albero

Ana Maria Gamo Albero has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Agonists of stimulator of interferon genes sting
    Patent number: 11701364
    Abstract: The invention provides compounds having STimulator of INterferon Genes (STING) agonistic bioactivity that can be used in the treatment of tumors in patients afflicted therewith. The compounds are of formula (I): as defined herein. Compounds for practice of a method of the invention can be delivered via oral delivery for systemic exposure, as well as delivered intratumorally. Antitumor therapy using a compound of formula (I) can further comprise administration of an effective dose of an immune-checkpoint targeting drug.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: July 18, 2023
    Assignee: The Scripps Research Institute
    Inventors: Luke L. Lairson, Emily Chin, Arnab K. Chatterjee, Manoj Kumar, Ana Maria Gamo Albero, Hank Michael James Petrassi, Peter G. Schultz, Chenguang Yu, Junko Tamiya, William Vernier, Anil Gupta, Ramkumar Modukuri
  • MONOCYCLIC AGONISTS OF STIMULATOR OF INTERFERON GENES STING
    Publication number: 20220288065
    Abstract: The invention provides compounds having STimulator of INterferon Genes (STING) agonistic bioactivity that can be used in the treatment of tumors inpatients afflicted therewith. The compounds are of formula (IA), formula (I), and formula (II): wherein the various substituents are as defined herein. Ring A is a 5- or 6-membered heteroaryl comprising 1, 2, or 3 N atoms, unsubstituted or substituted with 1, 2, or 3 groups as defined herein. Compounds for practice of a method of the invention can be delivered via oral delivery for systemic exposure, as well as delivered intratumorally. Antitumor therapy using a compound of formula (I) can further comprise administration of an effective dose of an immunecheckpoint targeting drug.
    Type: Application
    Filed: August 21, 2020
    Publication date: September 15, 2022
    Inventors: H. Michael PETRASSI, Chenguang YU, Jie WANG, Arnab K. CHATTERJEE, Ana Maria Gamo ALBERO, Anil GUPTA, Junko TAMIYA, Peter G. SCHULTZ, Kristen JOHNSON, Alan CHU, Emily N. CHIN, Luke L. LAIRSON
  • AGONISTS OF STIMULATOR OF INTERFERON GENES STING
    Publication number: 20210205321
    Abstract: The invention provides compounds having STimulator of INterferon Genes (STING) agonistic bioactivity that can be used in the treatment of tumors in patients afflicted therewith. The compounds are of formula (I): as defined herein. Compounds for practice of a method of the invention can be delivered via oral delivery for systemic exposure, as well as delivered intratumorally. Antitumor therapy using a compound of formula (I) can further comprise administration of an effective dose of an immune-checkpoint targeting drug.
    Type: Application
    Filed: February 21, 2019
    Publication date: July 8, 2021
    Inventors: Luke L. Lairson, Emily Chin, Arnab K. Chatterjee, Manoj Kumar, Ana Maria Gamo Albero, Hank Michael James Petrassi, Peter G. Schultz, Chenguang Yu, Junko Tamiya, William Vernier, Anil Gupta, Ramkumar Modukuri